Standard Treatment of Cervical Cancer Enhances Intestinal Dysbiosis and Correlates with NK Cell Exhaustion (#153)
Introduction: Intestinal microbiota (IM) influences NK cell regulation; however, its role in cervical cancer (CC) remains unclear. This study characterizes the IM of CC patients undergoing radiochemotherapy and its association with putatively exhausted NK cells.
Objective: To associate the IM profile in CC patients before and after radiochemotherapy with NK cell exhaustion.
Material & Methods: Cross-sectional analytical study with 27 CC patients pre-treatment (pre-tx), 22 patients post-treatment (post-tx), and 28 healthy women (HD). Stool samples were analyzed with 16S NGS, while peripheral blood and tumoral tissue were assessed by flow cytometry for NK cell exhaustion.
Results: IM of pre-tx CC patients exhibited Prevotella expansion and reduced α-diversity, which worsened post-tx, with further enrichment of Phascolarctobacterium and Escherichia-Shigella, alongside depletion of SCFA-producing bacteria. β-diversity significantly differed among HD, CC pre-tx, and CC post-tx. Functional predictions revealed a pro-inflammatory profile driven by LPS in CC patients. Peripheral CD56dim and CD56bright NK cells showed a significantly increased PD-1, LAG-3, and BTLA expression in CC pre-tx, which intensified post-tx. Putative exhaustion, defined as persistent co-expression of multiple inhibitory receptors, was confirmed with significantly enhanced co-expression of PD-1 with BTLA, LAG-3, TIM-3, and TIGIT on CD56dim NK cells in CC post-tx and was accentuated in tumor-infiltrating NK cells. Correlation analysis showed that immune checkpoint-positive NK cells were positively correlated with pathobionts (Phascolarctobacterium, Streptococcus) and negatively correlated with SCFA-producing bacteria.
Conclusion: Radiochemotherapy exacerbates intestinal dysbiosis dominated by inflammatory bacteria, potentially contributing to NK cell exhaustion. IM-targeted interventions before and during treatment could enhance anti-tumor responses in CC.
- Solorzano-Ibarra F, Alejandre-Gonzalez AG, Ortiz-Lazareno PC, Bastidas-Ramirez BE, Zepeda-Moreno A, Tellez-Bañuelos MC, et al. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis. Clin Exp Immunol. 2021;204(1):78–95.
- Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, et al. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol. 2019;155(2):237–44.